Johnson & Johnson

NYSE: JNJ
$155.71
+$0.54 (+0.3%)
Real Time Data Delayed 15 Min.

JNJ Articles

Johnson & Johnson reported its fourth-quarter financial results before the markets opened on Tuesday.
Johnson & Johnson is set to release its fourth-quarter financial results before the markets open Tuesday.
24/7 Wall St. has put together a preview of some of the Dow Jones Industrial Average companies (and others) that are reporting their quarterly results this week.
Investors need to keep in mind that the downside target for the Dow Jones Industrial Average will sink lower if the market keeps drifting south.
Johnson & Johnson is looking to save some money over the next few years and as a result it is taking action by restructuring its Medical Devices businesses.
24/7 Wall Street has evaluated three major Dow components in the pharmaceutical industry and presented the bullish and bearish case for each in 2016.
ThinkstockIn the second quarter of this year, U.S. corporate profits totalled $1.8 trillion after taxes. Massive corporate profit is not limited to the United States, although many of the world’s...
ThinkstockJanssen Biotech announced that the U.S. Food and Drug Administration (FDA) approved Yondelis (trabectedin) for the treatment of patients with unresectable or metastatic liposarcoma (LPS) or...
ThinkstockOctober 15, 2015: Markets opened higher on Thursday following a strong showing for stocks in both Asia and Europe. Biotech stocks continue to get new life, helping overcome some softness in...
Johnson & Johnson reported mixed third-quarter 2015 results before markets opened Tuesday morning.
Johnson & Johnson is scheduled to report its third-quarter financial results before the markets open on Tuesday.
24/7 Wall St. has put together a preview of some of the Dow Jones Industrial Average companies that are reporting their quarterly results this week.
Monday's top analyst upgrades, downgrades and initiations include AutoZone, Discover Financial Services, IBM, Microsoft, Twitter, Viacom and Wynn Resorts.
Its stock has suffered, but it is possible that Achillion’s interim trial results may have put the company back on the right track.
thinkstockSeptember 3, 2015: Markets opened higher on Thursday after the European Central Bank president indicated that the ECB would continue quantitative easing program. Markets in China and Hong...